conivaptan has been researched along with Disease Models, Animal in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Becker, JAJ; Bonnet, D; Durroux, T; Frantz, MC; GandÃa, J; Hibert, M; Le Merrer, J; Loison, S; Marsol, C; Mouillac, B; Pellissier, LP; Pflimlin, E; Valencia, C; Villa, P | 1 |
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Iwao, H; Izumi, Y; Miura, K | 1 |
| Elliott, JP; Jones, SM; Seo, JW; Snell, LD; Zeynalov, E | 1 |
| Collier, L; Decker, D; Lau, T; Leonardo, C; Olivera, R; Pennypacker, KR; Roma, G; Rowe, D; Seifert, H | 1 |
| Amiry-Moghaddam, M; Bhardwaj, A; Nakayama, S; Ottersen, OP | 1 |
| Elliott, JP; Jones, SM; Zeynalov, E | 1 |
| Arai, Y; Fujimori, A; Matsukawa, U; Miyata, K; Sasamata, M; Sudoh, K; Wada, K | 1 |
1 review(s) available for conivaptan and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic potential of vasopressin-receptor antagonists in heart failure.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzamides; Benzazepines; Body Water; Clinical Trials as Topic; Disease Models, Animal; Heart Failure; Homeostasis; Humans; Hyponatremia; Morpholines; Pyrroles; Receptors, Vasopressin; Spiro Compounds; Tolvaptan; Ventricular Remodeling | 2014 |
7 other study(ies) available for conivaptan and Disease Models, Animal
| Article | Year |
|---|---|
LIT-001, the First Nonpeptide Oxytocin Receptor Agonist that Improves Social Interaction in a Mouse Model of Autism.
Topics: Animals; Autistic Disorder; Blood-Brain Barrier; Disease Models, Animal; Female; HEK293 Cells; Humans; Interpersonal Relations; Ligands; Male; Mice; Mice, Knockout; Psychotropic Drugs; Pyrazoles; Pyrrolidines; Receptors, Opioid, mu; Receptors, Oxytocin; Structure-Activity Relationship | 2018 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Arginine-Vasopressin Receptor Blocker Conivaptan Reduces Brain Edema and Blood-Brain Barrier Disruption after Experimental Stroke in Mice.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood-Brain Barrier; Brain Edema; Disease Models, Animal; Mice; Receptors, Vasopressin; Stroke; Water-Electrolyte Balance | 2015 |
The Effects of Clinically Relevant Hypertonic Saline and Conivaptan Administration on Ischemic Stroke.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Brain; Brain Edema; Disease Models, Animal; Fluoresceins; Fluorescent Dyes; Immunohistochemistry; Infarction, Middle Cerebral Artery; Laser-Doppler Flowmetry; Macrophage Activation; Male; Microglia; Rats; Rats, Sprague-Dawley; Saline Solution, Hypertonic | 2016 |
Conivaptan, a Selective Arginine Vasopressin V1a and V2 Receptor Antagonist Attenuates Global Cerebral Edema Following Experimental Cardiac Arrest via Perivascular Pool of Aquaporin-4.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Aquaporin 4; Benzazepines; Brain Edema; Cardiopulmonary Resuscitation; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Arrest; Male; Mice; Mice, Inbred C57BL | 2016 |
Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Brain Edema; Disease Models, Animal; Infarction, Middle Cerebral Artery; Infusions, Intravenous; Male; Mice; Mice, Inbred C57BL; Random Allocation; Receptors, Vasopressin; Stroke | 2016 |
A novel vasopressin dual V1A/V2 receptor antagonist, conivaptan hydrochloride, improves hyponatremia in rats with syndrome of inappropriate secretion of antidiuretic hormone (SIADH).
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Disease Models, Animal; Diuretics; Dose-Response Relationship, Drug; Furosemide; Hyponatremia; Inappropriate ADH Syndrome; Injections, Intravenous; Male; Osmolar Concentration; Potassium; Rats; Rats, Wistar; Sodium; Water; Water-Electrolyte Balance | 2007 |